Prime editing system offers wide range of versatility in human cells, correcting disease-causing genetic variations
A team from the Broad Institute of MIT and Harvard has developed a new CRISPR genome-editing approach that has the potential to correct up to 89 percent of known disease-causing genetic variations.
Researchers have combined two of the most important proteins in molecular biology — CRISPR-Cas9 and a reverse transcriptase — into a single machine. The system, called prime editing, is capable of directly editing human cells in a precise, efficient, and highly versatile fashion.
“A major aspiration in the molecular life sciences is the ability to precisely make any change to the genome in any location. We think prime editing brings us closer to that goal,” said David Liu, core institute member, Richard Merkin Professor, vice chair of the faculty, and director of the Merkin Institute of Transformative Technologies in Healthcare at the Broad Institute of MIT and Harvard. “We’re not aware of another editing technology in mammalian cells that offers this level of versatility and precision with so few byproducts.”
Liu is the senior author of a paper published today in Nature that describes prime editing. The research was also led by first author Andrew Anzalone, a Jane Coffin Childs postdoctoral fellow in Liu’s lab at the Broad Institute.
A new CRISPR approach
Prime editing differs from previous genome-editing systems in that it uses RNA to direct the insertion of new DNA sequences in human cells.
The first CRISPR tool harnessed for genome editing in human cells, pioneered at the Broad Institute, MIT, and Harvard, was the Cas9 protein. Cas9 makes nearby breaks on each DNA strand, cutting the DNA entirely. These tools can disrupt target genes at a specific location and then make it possible to add new sequences through recombination of new DNA into the site, directed by the cell itself.
Base editing, first developed by Liu’s laboratory, builds on this technology, fusing Cas9 to proteins that can perform chemical reactions to change a single letter of DNA into another. Current base editors can make four types of single-base changes efficiently: C to T, T to C, A to G, and G to A.
The new prime editing system involves coupling Cas9 to a different protein called reverse transcriptase. The molecular complex uses one strand of the target DNA site to “prime,” or initiate, the direct writing of edited genetic information into the genome.
A new type of engineered guide RNA, called a pegRNA, directs the prime editor to its target site, where a modified Cas9 cuts one strand of the DNA. The pegRNA also contains additional RNA nucleotides encoding the new edited sequence. To transfer this information, the reverse transcriptase element reads the RNA extension and writes the corresponding DNA nucleotides into the target spot.
Edits made to order
In the Nature paper, the team demonstrated prime editing’s ability to precisely correct gene variants that cause sickle-cell anemia, requiring the conversion of a specific T to an A, and Tay-Sachs disease, requiring the removal of four DNA letters at a precise location in the genome.
The researchers further report a variety of successful edit types in human cells and primary mouse neurons, including all 12 possible ways to replace one DNA letter with another, insertions of new DNA segments up to 44 DNA letters long, precise deletions of up to 80 DNA letters, and modifications combining these different types of edits.
“With prime editing, we can now directly correct the sickle-cell anemia mutation back to the normal sequence and remove the four extra DNA bases that cause Tay-Sachs disease, without cutting DNA entirely or needing DNA templates,” said Liu, who is also a professor of chemistry and chemical biology at Harvard University and a Howard Hughes Medical Institute investigator. “The beauty of this system is that there are few restrictions on the edited sequence. Since the added nucleotides are specified by the pegRNA, they can be sequences that differ from the original strand by only one letter, that have additional or fewer letters, or that are various combinations of these changes.”
“The versatility of prime editing quickly became apparent as we developed this technology,” said Anzalone. “The fact that we could directly copy new genetic information into a target site was a revelation. We were really excited.”
The researchers report that prime editing achieves successful edits with a lower rate of undesired “off-target” changes compared with approaches that require making nearby breaks on each DNA strand. Prime editing can also make precise single-nucleotide changes in target sequences that base editors have difficulty accessing, according to the team’s data.
Liu’s team intends to continue optimizing prime editing, including by maximizing its efficiency in many different cell types, further investigating potential effects of prime editing on cells, additional testing in cell and animal models of disease, and exploring delivery mechanisms in animals to provide a potential path for human therapeutic applications.
The researchers and the Broad Institute are making this technology freely available to the academic and nonprofit communities, including by sharing vectors through the nonprofit Addgene. For these groups, no license is necessary.
The Broad Institute is making prime editing tools available to license nonexclusively for research and manufacturing by companies, and for the commercial development of tools and reagents. For human therapeutic use, the Broad Institute has licensed the technology to Prime Medicine under the inclusive innovation model. As has been publicly reported, Beam Therapeutics has received a sublicense from Prime Medicine for the use of prime editing in certain fields and for certain applications. (Liu is a consultant and co-founder of both Prime Medicine and Beam Therapeutics.)
Learn more: Genome editing with precision
The Latest on: Prime editing
via Google News
The Latest on: Prime editing
- Belgium’s first female prime minister is Jewishon October 28, 2019 at 1:09 pm
Sophie Wilmes is the first woman and the first Jewish person to become the prime minister of Belgium. Wilmes ... Michael Freilich, a Belgian lawmaker for the N-VA party and the former editor in chief ...
- KT edit: Brexit 'flextension' is more chaoson October 28, 2019 at 11:06 am
Going by precedent little will come of this episode unless the ruling Tories return with a brute majority if elections are held by December 12. A Conservative victory will make it easy for Prime ...
- Students defy prime minister to join Iraq protestson October 28, 2019 at 3:47 am
A spokesman for Prime Minister Adel Abdul Mahdi, whose position is increasingly precarious as ... Reporting by Ahmed Aboulenein; Additional reporting by a Reuters correspondent in Diwaniya; Editing by ...
- Calls between Netanyahu, 'Yediot' editor in Case 2000 exposedon October 27, 2019 at 10:53 am
The recordings of phone calls Prime Minister Benjamin Netanyahu had with Yediot Aharonot publisher Arnon "Noni" Moses were published Saturday on Channel 13. These recordings are central to Netanyahu's ...
- The Week That Wasn't: CRISPR Prime, New Flu Drug, Calm Brain for Long Lifeon October 25, 2019 at 1:57 pm
Biochemists at the Broad Institute published a paper in the journal Nature on what they call CRISPR prime, a new gene-editing tool they say is able to "correct 89% of known human pathogenic variants." ...
- There's Yet Another Gene Editing Technique, but It Has 1 Glaring Problemon October 24, 2019 at 9:50 am
This week, investors may have seen that a new gene editing technique will soon be available to scientists attempting to engineer DNA for human health applications. Dubbed "prime editing", some have ...
- New gene editing technology could correct 89% of genetic defectson October 23, 2019 at 1:17 pm
Scientists have developed a new gene-editing technology that could potentially correct up to 89% of genetic defects, including those that cause diseases like sickle cell anemia. The new technique is ...
- New CRISPR genome “prime editing” systemon October 22, 2019 at 8:44 pm
Researchers have come up with a new gene editing technology that could help patients with sickle cell anaemia and up 89 percent of other genetic defects. This new technique is called the “prime ...
- New “Prime Editing” Method Makes Only Single-Stranded DNA Cutson October 22, 2019 at 11:31 am
A new gene editing technique called prime editing, tested in human and mouse cells, rewrites DNA by only cutting a single strand to add, remove, or replace base pairs. The method may allow researchers ...
- What The New Gene Editing Tool 'Prime-Editing' Is All Abouton October 22, 2019 at 2:11 am
A research team at The Broad Institute has developed a new tool for making changes to DNA, called "Prime-Editing." Scientists say it's a major advance on the revolutionary gene editing technology ...
via Bing News